The revised financial guidance signaled a significant downturn, with adjusted EBITDA targets falling by as much as $115 million to a range of $500-$560 million. Parsons also lowered its revenue forecast to $6.2-$6.5 billion. Management attributed the shortfall to divestitures, lower pass-through costs, and the sudden cancellation of a confidential fixed-price contract. This specific program, which CEO Carey Smith described as being in a "wind-down state" during an earnings call last November, contributed $50 million in revenue at that time.

Financial results for the latest quarter underscored the company's struggle, with adjusted EBITDA falling approximately 72% year-over-year to $42 million, alongside a net loss of $15 million. Levi & Korsinsky is now reviewing whether Parsons Corporation provided investors with accurate information regarding its outlook. Shareholders who incurred losses are being asked to provide trade confirmations and purchase records for a no-cost evaluation of their potential claims.